Drugmaker Eli Lilly's 2Q profit falls 11 percent - BusinessWeek

Drugmaker Eli Lilly and Co.'s second-quarter earnings fell 11 percent as it hiked marketing and research expenses to gear for a wave of patent expirations that will slash sales for its top-selling drugs. The Indianapolis company said Thursday marketing, selling and administrative expenses climbed 16 percent to $2.04 billion as the company supported launches of the...